Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04633551 · ClinicalTrials.gov registry record · NA
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04633551 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 9 participants.
The verdict
NCT04633551, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Women who had an adverse pregnancy outcome (APO), such as preeclampsia, preterm birth, or gestational diabetes, have a higher risk for heart disease. Some of the extra risk for heart disease after APOs is thought to be caused by inflammation. Investigators will randomize women who had an APO in the past 3 years to receive an anti-inflammatory supplement or serve as a time control. Investigators will compare blood pressure, arterial stiffness, blood vessel reactivity, and blood markers of inflammation between women who did and did not receive the supplement. Investigators will determine women's attitudes about taking a dietary supplement and measure whether the participants who receive the supplement take all or most of the doses.
Interventions
- DIETARY_SUPPLEMENT Anti-inflammatory supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04633551
The ClinicalTrials.gov registry entry for NCT04633551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anti-inflammatory supplement is the first listed.
NCT04633551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04633551 about?
NCT04633551 is a clinical study titled "Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes". Women who had an adverse pregnancy outcome (APO), such as preeclampsia, preterm birth, or gestational diabetes, have a higher risk for heart disease. Some of the extra risk for heart disease after APOs is thought to be caused by inflammation. Investigators will randomize women who had an APO in the ...
What is the current status of trial NCT04633551?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-10-01. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT04633551?
The interventions under investigation include: Anti-inflammatory supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04633551?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.